@article{4a83186b568746319c7b1706e124fb0a,
title = "Discussion of Research Priorities for Gait Disorders in Parkinson's Disease",
abstract = "Gait and balance abnormalities develop commonly in Parkinson's disease and are among the motor symptoms most disabling and refractory to dopaminergic or other treatments, including deep brain stimulation. Efforts to develop effective therapies are challenged by limited understanding of these complex disorders. There is a major need for novel and appropriately targeted research to expedite progress in this area. The Scientific Issues Committee of the International Parkinson and Movement Disorder Society has charged a panel of experts in the field to consider the current knowledge gaps and determine the research routes with highest potential to generate groundbreaking data.",
keywords = "FOG, Parkinson's disease, balance, freezing, gait, research priorities",
author = "{The MDS Scientific Issues Committee} and Bohnen, {Nicolaas I.} and Costa, {Rui M.} and Dauer, {William T.} and Factor, {Stewart A.} and Nir Giladi and Mark Hallett and Lewis, {Simon J.G.} and Alice Nieuwboer and Nutt, {John G.} and Kaoru Takakusaki and Kang, {Un Jung} and Serge Przedborski and Papa, {Stella M.}",
note = "Funding Information: Prof. Giladi serves as a consultant to Sionara, NeuroDerm, Pharma2B, Denali, Neuron23, Sanofi‐Genzyme, Biogen, and AbbVie. He receives royalties from Lysosomal Therapeutics (LTI) and payment for lectures at AbbVie, Sanofi‐Genzyme, and Movement Disorder Society. He received research support from The Michael J. Fox Foundation, the National Parkinson Foundation, the European Union, and the Israel Science Foundation, as well as from Teva NNE program, Biogen, and Ionis. He receives support from the Sieratzki Family Foundation and the Aufzien Academic Center in Tel‐Aviv University. Funding Information: Dr. Papa has received research support from NIH‐NINDS, The Michael J. Fox Foundation, Pfizer, Inc., EnVivo Pharmaceuticals, Inc., Forum Pharmaceuticals, Inc., GeneGraft, LTD., Key Neurosciences, and Mochida Pharmaceuticals Co. LTD. She has been a consultant for Teva Neuroscience. Funding Information: Dr. Lewis is supported by a National Health and Medical Research Council Leadership Fellowship (1195830) and has received research funding from The Michael J. Fox Foundation and the Australian Research Council. Funding Information: Dr. Kang has received research funding from the NIH‐NINDS, Parkinson's Foundation, The Michael J. Fox Foundation for Parkinson's Research, Parekh Center, Fresco Institute, and Jain Foundation. He receives honorarium as Associate Editor for . Experimental Neurology Funding Information: Prof. Nieuwboer receives funding from the following: European Commission, Research Foundation Flanders, King Baudouin Foundation, The Michael J. Fox Foundation, Jacques and Gloria Gossweiler Foundation, and KU Leuven Internal Research Funds. Funding Information: Dr. Factor is supported by The Sartain Lanier Family Foundation. He been a consultant for Lundbeck, Sunovion, Biogen, Impel, Acorda, CereSpir. He has received education and research grants from Medtronics, Boston Scientific, Sun Pharmaceuticals Advanced Research Company, Biohaven, Impax, Lilly, US World Meds, Sunovion Therapeutics, Neurocrine, Vaccinex, Voyager, Jazz Pharmaceuticals, CHDI Foundation, The Michael J. Fox Foundation, NIH, and Parkinson Foundation. He receives royalties from Demos, Blackwell Futura, Springer for textbooks, and Uptodate. Other support is from Signant (Bracket Global LLC) and CNS Ratings LLC. Funding Information: Dr. Bohnen has received research funding from the National Institutes of Health (NIH), Department of Veterans Affairs, The Michael J. Fox Foundation, Eisai, and EIP Pharma. He has participated in an Eisai advisory board and received in kind research support from Expansion Therapeutics and Innovative Health Solutions. Publisher Copyright: {\textcopyright} 2021 International Parkinson and Movement Disorder Society",
year = "2022",
month = feb,
doi = "10.1002/mds.28883",
language = "English (US)",
volume = "37",
pages = "253--263",
journal = "Movement Disorders",
issn = "0885-3185",
publisher = "John Wiley and Sons Inc.",
number = "2",
}